Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infection.

Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infection. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infection. Abstract Text:

    john g carsonJohn G Carson,robin s turpinRobin S Turpin,henry huHenry Hu,larry maLarry Ma,samuel e wilsonSamuel E Wilson,

    ABSTRACT Background: Cost of treatment is an important consideration in antimicrobial agent selection for intra-abdominal infection. We analyzed the relation between the total cost of inpatient stay and the initial selection of antimicrobial agent. Methods: Actual costs of inpatient care were calculated for 1,234 patients treated at 22 hospitals with one of five antimicrobial regimens: Ampicillin/sulbactam (n = 428), ertapenem (n = 143), ceftriaxone (n = 101), levofloxacin (n = 245), or piperacillin/tazobactam (n = 317) for intra-abdominal infections. Length of stay (LOS), demographic data, diagnosis, disease severity index, intensive care unit (ICU) stay, and total and specific costs were obtained from a large hospital-based, service level, comparative database for five types of infection (appendicitis, cholecystitis, diverticulitis, pancreatitis, and postoperative infection). Results: The LOS was shorter for appendicitis (3.8 days) and cholecystitis (4.6 days) than for diverticulitis (11.4 days), pancreatitis (8.1 days), or postoperative infection (8.4 days). Length of stay and total cost were most closely related to severity index (p < 0.01) and ICU days (p < 0.01). When patient and hospital characteristics and correlations within hospitals were accounted for in the model, piperacillin/tazobactam was associated with significantly higher cost than ertapenem, ampicillin/sulbactam, and levofloxacin. Conclusions: In assessing pharmacoeconomic outcomes in the treatment of intra-abdominal infection, cost of treatment, although lower with certain antimicrobial agents, is dependent on severity-of-illness indicators.

    Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infection. Publishing Authors By Initials

    jg carsonJG Carson,rs turpinRS Turpin,h huH Hu,l maL Ma,se wilsonSE Wilson,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infection. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Surgical infections

    VOLUME: 9

    Page Numbers: 15-21

    Journal Abbreviation:

    ISSN: 1096-2964

    DAY: 26

    MONTH: Feb

    YEAR: 2008

    Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infection. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9815642

    Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infection. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infection. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infection.

    AFFILIATION: Department of Surgery, University of California, Irvine School of Medicine, Irvine, California.

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Surg Infect (Larchmt)

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Cost analysis of five antimicrobial regimens for the treatment of intra-abdominal infection Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News